Home › Drug maker Transcept rejects Shkreli play to boost ownership stake
 

Keywords :   


Drug maker Transcept rejects Shkreli play to boost ownership stake

2013-10-01 04:47:27| Biotech - Topix.net

Transcept Pharmaceuticals Inc. rejected a request from Retrophin Inc. to triple its ownership stake in the Richmond drug developer from 4.9 percent to up to 15 percent.

Tags: play drug ownership maker

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
More »